The Salad Station and Chowbotics have teamed up to bring a salad-making vending machine to multiple locations across Houston. Courtesy of The Salad Station

A healthy foods concept has selected Houston as its next spot to bring its salad-making robot — aptly named Sally. The Salad Station, a Louisiana-based restaurant group, has partnered with California-based Chowbotics to bring salad-making vending machines to Houstonians.

Chowbotics invented Sally, which serves customizable, made-to-order salads, snacks, breakfast bowls, and grain bowls. Scott Henderson, founder and president of The Salad Station, tells InnovationMap that the discussion with Chowbotics about being the company's operational manager started in 2018.

"In seven states, from Texas to Florida, The Salad Station does operations for Sally the robot," says Henderson. "We both have a passion for bringing fresh products to people as many hours of the day as possible."

Henderson tells InnovationMap that he saw potential for the robot to increase opportunities for the chain's franchisees, increasing the amount of locations one person could own.

"We started looking at locations for Sally the robot and just in the Texas Medical Center alone, we feel like it could be 60 to 80 placements," says Henderson.

Due to the massive potential, The Salad Station entered into a partnership with Houston-based RoboFresh as the group's commissary to bring in more than 100 robots by 2022. Henderson tells InnovationMap that there will be 10 salad-making robots in the Texas Medical Center by 2020.

According to Henderson, the robot holds 22 unique ingredients, including two different lettuces, six topping options, and a dressing. The customer is able to customize their ingredients to create the salad of their choice. Payment is completed by credit card or Apple Pay, with most salads costing $7 to $8.

Henderson tells InnovationMap that the number one question they are asked at salad robot facilities is how the machine's ingredients stay fresh.

"We service the machines, at a minimum, twice a day, everyday," says Henderson. "Every morning and afternoon, we have people that go to the robots to bring fresh ingredients and to sanitize the outside of the machine."

Each ingredient is loaded in an airtight container, Henderson says.

"So, from the prepping in our Salad Station restaurants to delivering and installing it, there is no touch of product," says Henderson.

Henderson tells InnovationMap that each canister has an expiration date. For example, the expiration date on spinach is two days, so if the ingredient is not sold within that time frame, it no longer shows an option for the customer.

"Anytime the robot goes over 41 degrees for more than five minutes it disables itself, so customers cannot use the machine until we come back on site and change out the ingredients," says Henderson, adding that the robot maintains a consistent temperature of 34 degrees, keeping produce fresh and crisp.

The salad vending machines are just the beginning of growth in the Space City. The Salad Station is expanding into the Houston area with their first local brick and mortar location in Webster. In addition to the new opening, the franchise is expected to open additional locations across the greater Houston area in the next few years.

"That's where we're at for Texas, we're searching for local people, mainly in the Houston surrounding areas, that want to own their own business," says Henderson.

He adds that he believes the company's family-friendly values and hours will draw in more individuals to help open franchise locations of the fresh food chain.

The Salad Station was founded by Scott Henderson and his mother and business partner Cindy Henderson in 2012, the first store opening in Hammond, LA. Henderson tells InnovationMap that he started franchising the concept in 2014 and locating partners in nearby states to bring The Salad Station to new markets. The restaurant group currently has locations in Louisiana, Mississippi, Alabama, and Florida.

Johnmike Heroman, the head of franchise development at The Salad Station, tells InnovationMap that the chain is currently looking for potential franchise owners in the Houston area and feedback on placement options for Sally's next location.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.